Welcome to visit Acta Anatomica Sinica! Today is
Chinese
Progress of blood cells reprogramming to induced pluripotent stem cells
ZHANG Yue WU Bin GONG Tian-tian LEI Lei SHAN Zhi-yan*
Acta Anatomica Sinica ›› 2015, Vol. 46 ›› Issue (6) : 852-856.
Progress of blood cells reprogramming to induced pluripotent stem cells
Blood cell / Induced pluripotent stem cell / Reprogramming / Application
［1］Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors［J］. Cell, 2006, 126(4): 663-676.
［2］Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors［J］. Cell, 2007, 131(5): 861-872.
［3］Yu J, Vodyanik MA, SmugaOtto K, et al. Induced pluripotent stem cell Lines derived from human somatic cells［J］. Science, 2007,318(5858): 1917-1920.
［4］Di Stefano B, Graf T. Very rapid and efficient generation of induced pluripotent stem cells from mouse Pre-B cells［J］. Methods Mol Biol, 2014 ［Epub ahead of print］.
［5］Merkl C, Saalfrank A, Riesen N, et al. Efficient generation of rat induced pluripotent stem cells using a non-viral inducible vector［J］. PLoS One, 2013, 8(1): e55170.
［6］Shimozawa N. Cynomolgus monkey induced pluripotent stem cells generated by using allogeneic genes［J］. Methods Mol Biol, 2014［Epub ahead of print］.
［7］Fujie Y, Fusaki N, Katayama T, et al. New type of sendai virus vector provides transgenefree iPS cells derived from chimpanzee blood［J］. PLoS One, 2014, 9(12): e113052.［8］Li X, Shan ZY, Wu YS, et al. Generation of neural progenitors from induced Bama miniature pig pluripotent cells［J］. Reproduction, 2014, 147(1): 65-72.
［9］Marchetto MC, Carromeu C, Acab A, et al. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells［J］. Cell, 2010, 143(4): 527-539.
［10］Ikehata H, Masuda T, Sakata H, et al. Analysis of mutation spectra in UVB-exposed mouse skin epidermis and dermis: frequent occurrence of C→T transition at methylated CpG-associated dipyrimidine sites［J］. Environ Mol Mutagen, 2003, 41(4): 280-292.
［11］Yamanaka S. Patient-specific pluripotent stem cells become even more accessible［J］. Cell Stem Cell, 2010, 7(1): 1-2.
［12］Loh YH, Hartung O, Li H, et al. Reprogramming of T cells from human peripheral blood［J］. Cell Stem Cell, 2010, 7(1): 15-19.
［13］Staerk J, Dawlaty MM, Gao Q, et al. Reprogramming of human peripheral blood cells to induced pluripotent stem cells［J］. Cell Stem Cell, 2010, 7(1): 20-24.
［14］Chou BK, Mali P, Huang X, et al. Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures［J］. Cell Res, 2011, 21(3): 518-529.
［15］Kim K, Doi A, Wen B, et al. Epigenetic memory in induced pluripotent stem cells［J］. Nature, 2010, 467(7313): 285-290.
［16］Hanna J, Markoulaki S, Schorderet P, et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency［J］. Cell, 2008, 133(2): 250-264.
［17］Hong H, Takahashi K, Ichisaka T, et al. Suppression of induced pluripotent stem cell generation by the p53p21 pathway［J］. Nature, 2009, 460(7259): 1132-1135.
［18］Eminli S, Foudi A, Stadtfeld M, et al. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells［J］. Nat Genet, 2009, 41(9): 968-976.
［19］Di Stefano B, Sardina JL, van Oevelen C, et al. C/EBPalpha poises B cells for rapid reprogramming into induced pluripotent stem cells［J］. Nature, 2014, 506(7487): 235-239.［20］Hubbard JJ, Sullivan SK, Mills JA, et al. Efficient iPS cell generation from blood using episomes and HDAC inhibitors［J］. J Vis Exp, 2014,(92): e52009.
［21］Hu K, Yu J, Suknuntha K, et al. Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells［J］. Blood, 2011, 117(14):109-119.
［22］Su RJ, Neises A, Zhang XB,et al. Generation of iPS cells from human peripheral blood mononuclear cells using episomal vectors［J］. Methods Mol Biol, 2014［Epub ahead of print］.
［23］Seki T, Yuasa S, Oda M, et al. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells［J］. Cell Stem Cell, 2010, 7(1): 11-14.
［24］Merling RK, Sweeney CL, Choi U, et al.Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells［J］.Blood, 2013,121(14):e98-107.
［25］Zhou H, Martinez H, Sun B, et al. Rapid and efficient generation of transgene-free iPSC from a small volume of cryopreserved blood［J］. Stem Cell Rev, 2015, 11(4): 652-665.［26］Ye Z, Zhan H, Mali P, et al. Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders［J］. Blood, 2009, 114(27): 5473-5480.
［27］Hiramoto T, Ebihara Y, Mizoguchi Y, et al. Wnt3a stimulates maturation of impaired neutrophils developed from severe congenital neutropenia patient-derived pluripotent stem cells［J］. Proc Natl Acad Sci USA, 2013, 110(8): 3023-3028.
/
| 〈 |
|
〉 |
